Welcome to the annual meeting for AtriCure, Inc. Our host for today's call is Michael Carrel, President and CEO. I will now turn the call over to your host. Mr. Carrel, you may begin.
Good morning, everyone. Welcome to the 2026 annual meeting of stockholders of AtriCure. I'm Michael Carrel, President and CEO, and also a member of our board of directors. On behalf of our entire board, our officers, and employees, I'd like to thank you for attending this meeting today. We are conducting this meeting virtually so that our stockholders can participate regardless of their geographic location. As a reminder, the agenda and rules of conduct for today's meeting are posted on this meeting's website. Following the conclusion of my remarks, there will be a brief opportunity for questions about the proxy items voted upon during this meeting. Questions from stockholders may be submitted in the text box provided on the web portal during this meeting. We're asking stockholders who submit a question to include their name and email address as well.
If you submit a question and we do not have an opportunity to answer it at this meeting, someone from AtriCure will follow up with you after the meeting. If there are any matters of individual concern to a stockholder and not of general concern to all stockholders, or if the question posed was not otherwise answered, such matters may be raised separately after the annual meeting by contacting investor relations at (513) 644-4484. I now would like to introduce the other members of our current board of directors who are present. Reggie Groves, Kris Johnson, Shlomi Nachman, Karen Prange, Deborah Telman, Sven A. Wehrwein, Robert White, and Maggie S. Yuen. Now turning to the 5 proposals for consideration by stockholders, all of which are fully described in the proxy statement. Proposal number 1.
Our first proposal is the election of nine directors to hold office for one year or until a successor is duly elected and qualifies. The nominees are Regina Groves, B. Kristine Johnson, Shlomi Nachman, Karen N. Prange, Deborah H. Telman, Sven A. Wehrwein, Robert S. White, Maggie S. Yuen, and me. Proposal number 2. The second proposal is the ratification of the appointment of the company's independent registered public accounting firm. Although the audit committee has the sole authority to appoint the company's auditors, the committee would like to know the opinion of stockholders regarding its appointment of Deloitte as auditors for 2026. Proposal number 3. The third proposal is the amendment of the 2023 Stock Incentive Plan to increase the number of authorized shares by 1,500,000. Proposal number 4.
The fourth proposal is the amendment of the 2018 Employee Stock Purchase Plan to increase its number of authorized shares by 750,000. Proposal number 5. The fifth proposal relates to an advisory vote on the compensation of our named executive officers. This proposal is required by the Dodd-Frank Wall Street Reform and Consumer Protection Act and is referred to as the say on pay vote. We ask that stockholders approve on an advisory basis the compensation of our named executive officers as disclosed in the proxy statement. At this time, are there any questions or discussion related to any of the proposals? Since there are no questions or comments and the voting is now closed, I would like to report the voting results, all of which are subject to final tabulation.
Approximately 91%, which is over 46 million shares of the approximately 50.6 million outstanding shares, have been voted. All 9 nominees proposed by the board of directors were elected. With respect to the proposals to ratify the appointment of our independent registered public accounting firm, amend the 2023 Stock Incentive Plan, amend the Employee Stock Purchase Plan, and approve the compensation of our named executive officers on an advisory basis, all have been approved. Since there's no other business to conduct at this meeting, I declare the meeting adjourned. Thank you to everyone, and have a great day.
This now concludes today's meeting. Thank you for attending. Have a wonderful rest of your day.